Treatment of Excess Tearing (Epiphora)
Begin by treating reflex tearing from ocular surface disease with lubricants and anti-inflammatory therapy before considering any anatomical interventions, as this resolves the majority of cases and prevents unnecessary surgery. 1
Diagnostic Framework
The critical first step is distinguishing between two fundamentally different mechanisms 2:
- Reflex tearing (hypersecretion): Excessive tear production triggered by ocular surface irritation, dry eye, or meibomian gland dysfunction 1, 2
- True epiphora (drainage failure): Mechanical obstruction or lacrimal pump failure preventing normal tear drainage 2, 3
Key Clinical Clues
Reflex tearing indicators 1:
- Bilateral presentation
- Associated ocular surface symptoms (burning, foreign body sensation)
- Positive dry eye testing (reduced tear break-up time, Schirmer test abnormalities)
- Patent lacrimal system on irrigation
Anatomical obstruction indicators 3:
- Unilateral presentation (especially in men, older patients)
- Lower lid malposition (39.5% of male cases)
- Punctal stenosis (more common in younger women, 34.6%)
- Nasolacrimal duct obstruction (29% of referred cases)
Treatment Algorithm
Step 1: Optimize Ocular Surface (First-Line for All Patients)
Initiate lubricant therapy 1:
- Carboxymethylcellulose 0.5-1%, carmellose sodium, or hyaluronic acid drops during the day
- Lipid-containing drops if meibomian gland dysfunction is present
- Petrolatum ointment at bedtime, particularly if nocturnal lagophthalmos exists
Add anti-inflammatory treatment for underlying dry eye 1:
- Topical cyclosporine 0.05% or lifitegrast for chronic dry eye disease 4
- Short-term low-dose topical corticosteroids (loteprednol etabonate 0.5% or fluorometholone) for 2-4 weeks to suppress inflammation 4, 5
- Monitor for steroid-induced IOP elevation and cataract formation 4
Recent evidence for unexplained epiphora 5:
- Combined therapy with loteprednol etabonate 0.5% twice daily for 10 days plus nepafenac 0.3% once daily for 1 month significantly reduced tear meniscus measurements and Munk epiphora scores
- This approach is particularly valuable when no clear anatomical cause is identified
Step 2: Address Anatomical Abnormalities (Only After Surface Optimization)
Correct eyelid malposition 1, 3:
- Lower lid laxity repair for ectropion/entropion (33.3% of cases)
- This is especially common in older men
- Punctal dilation or surgical punctoplasty
- More prevalent in women (34.6% vs 22.4% in men)
Step 3: Lacrimal Drainage Surgery (Last Resort)
Dacryocystorhinostomy (DCR) for confirmed nasolacrimal obstruction 6:
- External DCR remains the gold standard
- Powered endoscopic DCR shows comparable outcomes
- Only proceed after optimizing ocular surface and correcting anatomical issues 1
Critical Pitfalls to Avoid
Do not perform premature surgical intervention 1:
- Many cases of apparent "obstruction" are actually reflex tearing that resolves with medical management
- Always optimize the ocular surface first
Beware of paradoxical epiphora from punctal plugs 4, 1:
- Punctal occlusion for dry eye can cause overflow tearing
- Use cautious trial occlusion before permanent closure
- 56% of silicone plugs are retained at 2 years, but spontaneous loss can lead to canalicular stenosis (34% at 2 years) 4
Consider malignancy in atypical presentations 7:
- Chronic unilateral epiphora, especially in older patients, warrants thorough evaluation
- Lacrimal sac squamous cell carcinoma can masquerade as simple nasolacrimal obstruction
- Biopsy any abnormal tissue encountered during surgery
Recognize multifactorial etiology 3:
- 22% of epiphora cases have multiple contributing factors
- Address all identified causes sequentially for optimal results
Special Considerations
Gender and age differences 3:
- Women present younger with punctal stenosis and nasolacrimal obstruction, often unilaterally
- Men present older with eyelid laxity as the predominant cause
Avoid punctal plugs in inflammatory conditions 4:
- Contraindicated in rosacea conjunctivitis and allergic conjunctivitis
- May exacerbate symptoms by retaining inflammatory mediators